vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Terreno Realty Corp (TRNO). Click either name above to swap in a different company.
Terreno Realty Corp is the larger business by last-quarter revenue ($137.5M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). Terreno Realty Corp runs the higher net margin — 115.1% vs -38.1%, a 153.1% gap on every dollar of revenue. On growth, Terreno Realty Corp posted the faster year-over-year revenue change (32.6% vs 20.2%). Over the past eight quarters, Terreno Realty Corp's revenue compounded faster (27.2% CAGR vs 24.8%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Terreno Realty Corp is a publicly traded real estate investment trust that specializes in owning, operating, and acquiring high-quality industrial real estate assets. Its portfolio mainly includes distribution warehouses and logistics facilities located in high-demand coastal U.S. metropolitan markets, serving tenants across e-commerce, last-mile delivery, retail supply chain, and light manufacturing segments.
PRCT vs TRNO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $83.1M | $137.5M |
| Net Profit | $-31.6M | $158.2M |
| Gross Margin | 64.9% | — |
| Operating Margin | -4.1% | — |
| Net Margin | -38.1% | 115.1% |
| Revenue YoY | 20.2% | 32.6% |
| Net Profit YoY | -27.9% | 107.9% |
| EPS (diluted) | $-0.56 | $1.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $137.5M | ||
| Q3 25 | $83.3M | $116.2M | ||
| Q2 25 | $79.2M | $112.2M | ||
| Q1 25 | $69.2M | $110.4M | ||
| Q4 24 | $68.2M | $103.7M | ||
| Q3 24 | $58.4M | $99.6M | ||
| Q2 24 | $53.4M | $94.2M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | $158.2M | ||
| Q3 25 | $-21.4M | $103.4M | ||
| Q2 25 | $-19.6M | $93.3M | ||
| Q1 25 | $-24.7M | $48.1M | ||
| Q4 24 | $-18.9M | $76.1M | ||
| Q3 24 | $-21.0M | $36.6M | ||
| Q2 24 | $-25.6M | $35.7M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 65.4% | — | ||
| Q1 25 | 63.9% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 59.0% | — |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | — | ||
| Q3 25 | -27.8% | — | ||
| Q2 25 | -28.0% | — | ||
| Q1 25 | -39.7% | — | ||
| Q4 24 | -28.9% | — | ||
| Q3 24 | -38.4% | — | ||
| Q2 24 | -50.3% | — |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | 115.1% | ||
| Q3 25 | -25.7% | 88.9% | ||
| Q2 25 | -24.7% | 83.1% | ||
| Q1 25 | -35.8% | 43.6% | ||
| Q4 24 | -27.6% | 73.4% | ||
| Q3 24 | -35.9% | 36.8% | ||
| Q2 24 | -48.0% | 37.9% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $1.54 | ||
| Q3 25 | $-0.38 | $1.00 | ||
| Q2 25 | $-0.35 | $0.90 | ||
| Q1 25 | $-0.45 | $0.47 | ||
| Q4 24 | $-0.34 | $0.78 | ||
| Q3 24 | $-0.40 | $0.37 | ||
| Q2 24 | $-0.50 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $25.0M |
| Total DebtLower is stronger | $51.7M | $943.3M |
| Stockholders' EquityBook value | $347.7M | $4.1B |
| Total Assets | $487.1M | $5.4B |
| Debt / EquityLower = less leverage | 0.15× | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $25.0M | ||
| Q3 25 | $294.3M | $26.2M | ||
| Q2 25 | $302.7M | $128.4M | ||
| Q1 25 | $316.2M | $156.5M | ||
| Q4 24 | $333.7M | $18.1M | ||
| Q3 24 | $196.8M | $243.7M | ||
| Q2 24 | $214.1M | $182.0M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | $943.3M | ||
| Q3 25 | $51.6M | $1.0B | ||
| Q2 25 | $51.5M | $742.4M | ||
| Q1 25 | $51.5M | $741.9M | ||
| Q4 24 | $51.5M | $823.4M | ||
| Q3 24 | $51.4M | $672.2M | ||
| Q2 24 | $51.4M | $772.0M |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $4.1B | ||
| Q3 25 | $380.3M | $4.0B | ||
| Q2 25 | $385.8M | $3.9B | ||
| Q1 25 | $389.2M | $3.9B | ||
| Q4 24 | $402.2M | $3.7B | ||
| Q3 24 | $241.2M | $3.6B | ||
| Q2 24 | $251.8M | $3.4B |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $5.4B | ||
| Q3 25 | $511.5M | $5.3B | ||
| Q2 25 | $513.1M | $5.0B | ||
| Q1 25 | $519.4M | $4.9B | ||
| Q4 24 | $534.0M | $4.8B | ||
| Q3 24 | $374.1M | $4.6B | ||
| Q2 24 | $374.4M | $4.5B |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | 0.23× | ||
| Q3 25 | 0.14× | 0.26× | ||
| Q2 25 | 0.13× | 0.19× | ||
| Q1 25 | 0.13× | 0.19× | ||
| Q4 24 | 0.13× | 0.22× | ||
| Q3 24 | 0.21× | 0.19× | ||
| Q2 24 | 0.20× | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $271.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $271.9M | ||
| Q3 25 | $-6.6M | $79.5M | ||
| Q2 25 | $-15.0M | $60.6M | ||
| Q1 25 | $-17.0M | $61.4M | ||
| Q4 24 | $-32.4M | $232.7M | ||
| Q3 24 | $-18.8M | $70.0M | ||
| Q2 24 | $-15.7M | $64.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | — | ||
| Q3 25 | $-9.5M | — | ||
| Q2 25 | $-17.8M | — | ||
| Q1 25 | $-18.8M | — | ||
| Q4 24 | $-33.6M | — | ||
| Q3 24 | $-19.0M | — | ||
| Q2 24 | $-16.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | — | ||
| Q3 25 | -11.4% | — | ||
| Q2 25 | -22.5% | — | ||
| Q1 25 | -27.2% | — | ||
| Q4 24 | -49.2% | — | ||
| Q3 24 | -32.6% | — | ||
| Q2 24 | -31.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 2.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 0.65× | ||
| Q1 25 | — | 1.28× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | — | 1.91× | ||
| Q2 24 | — | 1.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
TRNO
| Disposal Group Disposed Of By Sale Not Discontinued Operations | $109.5M | 80% |
| Other | $23.8M | 17% |
| At Market Equity Offering Program500Million | $4.1M | 3% |